Comparison of physical activity and quality of life in home haemodialysis (HHD) patients versus conventional in-centre haemodialysis (ICHD) patients: the observational, longitudinal, prospective, international, multicentric SeCoIA study protocol

Natalia Target, Cécile Courivaud, Pierre Antoine Michel, Salima Daoud, Michel Thomas, Natalia Target, Cécile Courivaud, Pierre Antoine Michel, Salima Daoud, Michel Thomas

Abstract

Background: Home haemodialysis (HHD), has shown improved clinical outcomes, as well as a better quality of life, compared to conventional in-centre haemodialysis (ICHD) but still has a global low prevalence among end-stage renal disease patients. Haemodialysis (HD) patients tend to be sedentary but only few studies, mainly in North American ICHD patients, have evaluated the level of activity in HD patients.

Methods: SeCoIA is an observational, longitudinal, prospective, international, multicentric, study, conducted in metropolitan France and Belgium. The main objective of the study is to quantify the physical activity measured by the total daily number of steps, in HHD patients compared to ICHD patients. The SeCoIA study will include 80 HHD patients and 80 ICHD patients,. Secondary objectives will be to characterize the HHD population and to confirm HHD efficiency on clinical parameters, as well as quality of life (QoL), in current practice. Physical activity will be measured by a 3-axis accelerometer. Accelerometers have been shown to provide accurate information, on both physical activity and sedentary behaviour. Patients will be instructed to wear the device and complete a patient diary 7 consecutive days after inclusion and the first week of each month for 12 months. Decision to undergo HDD or ICHD is independent of the study and follow-up frequency remains at the discretion of the physician/centre. QoL and quality of sleep will be respectively assessed by the Kidney Disease Quality of Life 1.2 (KDQOL™) and the Pittsburg Sleep Quality index (PSQI) questionnaires at inclusion, 6- and 12-month visits. Patients presenting a restless leg syndrome (RLS) will also complete the International Restless Legs Syndrome rating scale (IRLS) questionnaire.

Discussion: The SeCoIA study will be the first large cohort study (160 patients) evaluating physical activity, objectively measured with a 3-axis accelerometer, in HHD versus ICHD patients. The present study will also include a comparison of QoL with a focus on RLS between HHD and ICHD. It is anticipated that HHD patients will have an improved physical activity and QoL which should encourage physicians to further promote HHD.

Trial registration: Clinical trial NCT03737578 study registered on November 9, 2018 (Retrospectively registered).

Keywords: 3-axis accelerometer; End-stage renal disease; Home haemodialysis; Physical activity; Quality of life; Restless leg syndrome.

Conflict of interest statement

NT, CC and PAM have no conflict of interest. SD is an employee of Monitoring Force, a contract research organisation working for different pharmaceutical companies. MT is an employee of Physidia SAS.

Figures

Fig. 1
Fig. 1
Flow chart of the SeCoIA study

References

    1. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388:1459–1544. doi: 10.1016/S0140-6736(16)31012-1.
    1. Levin A, Tonelli M, Bonventre J, Coresh J, Donner J-A, Fogo AB, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet Lond Engl. 2017;390:1888–1917. doi: 10.1016/S0140-6736(17)30788-2.
    1. rapportrein2016.pdf. . Accessed 22 Jan 2019.
    1. Miller BW, Himmele R, Sawin D-A, Kim J, Kossmann RJ. Choosing home hemodialysis: a critical review of patient outcomes. Blood Purif. 2018;45:224–229. doi: 10.1159/000485159.
    1. Eneanya ND, Maddux DW, Reviriego-Mendoza MM, Larkin JW, Usvyat LA, van der Sande FM, et al. Longitudinal patterns of health-related quality of life and dialysis modality: a national cohort study. BMC Nephrol. 2019;20:7. doi: 10.1186/s12882-018-1198-5.
    1. FHN Trial Group. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287–2300. doi: 10.1056/NEJMoa1001593.
    1. Jaber BL, Finkelstein FO, Glickman JD, Hull AR, Kraus MA, Leypoldt JK, et al. Scope and design of the following rehabilitation, economics and everyday-Dialysis outcome measurements (FREEDOM) study. Am J Kidney Dis Off J Natl Kidney Found. 2009;53:310–320. doi: 10.1053/j.ajkd.2008.07.013.
    1. Finkelstein FO, Schiller B, Daoui R, Gehr TW, Kraus MA, Lea J, et al. At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int. 2012;82:561–569. doi: 10.1038/ki.2012.168.
    1. Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, et al. Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol CJASN. 2011;6:1049–1056. doi: 10.2215/CJN.10451110.
    1. Johansen KL, Chertow GM, Ng AV, Mulligan K, Carey S, Schoenfeld PY, et al. Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int. 2000;57:2564–2570. doi: 10.1046/j.1523-1755.2000.00116.x.
    1. Avesani CM, Trolonge S, Deléaval P, Baria F, Mafra D, Faxén-Irving G, et al. Physical activity and energy expenditure in haemodialysis patients: an international survey. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012;27:2430–4.
    1. Hayhurst WSG, Ahmed A. Assessment of physical activity in patients with chronic kidney disease and renal replacement therapy. SpringerPlus. 2015;4:536. doi: 10.1186/s40064-015-1338-3.
    1. Carvalho EV, Reboredo MM, Gomes EP, Teixeira DR, Roberti NC, Mendes JO, et al. Physical activity in daily life assessed by an accelerometer in kidney transplant recipients and hemodialysis patients. Transplant Proc. 2014;46:1713–1717. doi: 10.1016/j.transproceed.2014.05.019.
    1. Gomes EP, Reboredo MM, Carvalho EV, Teixeira DR, d’Ornellas CLFC, GFF F, et al. Physical Activity in Hemodialysis Patients Measured by Triaxial Accelerometer. BioMed Res Int. 2015;2015:645645. doi: 10.1155/2015/645645.
    1. Torino C, Manfredini F, Bolignano D, Aucella F, Baggetta R, Barillà A, et al. Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the EXCITE trial. Kidney Blood Press Res. 2014;39:205–211. doi: 10.1159/000355798.
    1. Manfredini F, Mallamaci F, D’Arrigo G, Baggetta R, Bolignano D, Torino C, et al. Exercise in patients on Dialysis: a multicenter, randomized clinical trial. J Am Soc Nephrol JASN. 2017;28:1259–1268. doi: 10.1681/ASN.2016030378.
    1. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J. 2006;27:1040–1055. doi: 10.1183/09031936.06.00064105.
    1. Lee I-M, Shiroma EJ. Using accelerometers to measure physical activity in large-scale epidemiologic studies: issues and challenges. Br J Sports Med. 2014;48:197–201. doi: 10.1136/bjsports-2013-093154.
    1. Marcus BH, Simkin LR. The stages of exercise behavior. J Sports Med Phys Fitness. 1993;33:83–88.
    1. Boini S, Leplege A, Loos Ayav C, Français P, Ecosse E, Briançon S. Measuring quality of life in end-stage renal disease. Transcultural adaptation and validation of the specific kidney disease quality of life questionnaire. Nephrol Ther. 2007;3:372–383. doi: 10.1016/j.nephro.2007.05.005.
    1. Blais FC, Gendron L, Mimeault V, Morin CM. Evaluation of insomnia: validity of 3 questionnaires. L’Encephale. 1997;23:447–453.
    1. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–132. doi: 10.1016/S1389-9457(02)00258-7.
    1. MR 001 Recherches dans le domaine de la santé avec recueil du consentement. . Accessed 9 Nov 2020.
    1. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data ProtectionRegulation). . Accessed 9 Nov 2020.
    1. Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev. 2011:CD003236.
    1. Panaye M, Kolko-Labadens A, Lasseur C, Paillasseur J-L, Guillodo MP, Levannier M, et al. Phenotypes influencing low physical activity in maintenance dialysis. J Ren Nutr Off J Counc Ren Nutr Natl Kidney Found. 2015;25(1):31–9.
    1. Moorman D, Suri R, Hiremath S, Jegatheswaran J, Kumar T, Bugeja A, et al. Benefits and barriers to and desired outcomes with exercise in patients with ESKD. Clin J Am Soc Nephrol CJASN. 2019.
    1. Cornelis T, Tennankore KK, Goffin E, Rauta V, Honkanen E, Őzyilmaz A, et al. An international feasibility study of home haemodialysis in older patients. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2014;29(12):2327–33. 10.1093/ndt/gfu260.
    1. Derrett S, Samaranayaka A, Schollum JBW, McNoe B, Marshall MR, Williams S, et al. Predictors of health deterioration among older adults after 12 months of Dialysis therapy: a longitudinal cohort study from New Zealand. Am J Kidney Dis Off J Natl Kidney Found. 2017;70:798–806. doi: 10.1053/j.ajkd.2017.06.023.
    1. MacGregor MS, Agar JWM, Blagg CR. Home haemodialysis-international trends and variation. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2006;21:1934–1945.
    1. v2 CH1 Incidence, Prevalence, Patient Characteristics, and Treatment Modalities. . Accessed 7 Feb 2019.
    1. Trinh E, Na Y, Sood MM, Chan CT, Perl J. Racial differences in home Dialysis utilization and outcomes in Canada. Clin J Am Soc Nephrol CJASN. 2017;12:1841–1851. doi: 10.2215/CJN.03820417.
    1. Jayanti A, Foden P, Rae A, Morris J, Brenchley P, Mitra S. The influence of renal Centre and patient Sociodemographic factors on home Haemodialysis prevalence in the UK. Nephron. 2017;136:62–74. doi: 10.1159/000452927.
    1. ANZDATA Australia and New Zealand Dialysis and Transplant Registry. . Accessed 7 Feb 2019.
    1. Gottlieb DJ, Somers VK, Punjabi NM, Winkelman JW. Restless legs syndrome and cardiovascular disease: a research roadmap. Sleep Med. 2017;31:10–17. doi: 10.1016/j.sleep.2016.08.008.
    1. Baiardi S, Mondini S, Baldi Antognini A, Santoro A, Cirignotta F. Survival of Dialysis patients with restless legs syndrome: a 15-year follow-up study. Am J Nephrol. 2017;46:224–230. doi: 10.1159/000479938.
    1. Aukerman MM, Aukerman D, Bayard M, Tudiver F, Thorp L, Bailey B. Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med JABFM. 2006;19:487–493. doi: 10.3122/jabfm.19.5.487.
    1. Exercise training for adults with chronic kidney disease. - PubMed - NCBI. . Accessed 11 Feb 2019.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する